Insulin Storage and Labeling Deficiency
Penalty
Summary
Surveyors observed that insulin medications, including Basaglar KwikPen, Insulin Lispro vials, Tresiba FlexTouch, Admelog, and Lantus, were stored on the 100 and 300 hall medication carts without proper labeling. Specifically, these insulin pens and vials were found to be opened, undated, and lacking resident identifiers. These observations were confirmed during interviews with both an LPN and an RN, who verified the presence of undated and unlabeled insulin on the respective medication carts. The facility's policy on medication storage requires that all drugs and biologics be stored in a safe, secure, and orderly manner, in their original packaging or dispensing systems, and that any containers with missing or incomplete labels be returned to the pharmacy for proper labeling before storage. The failure to label and date insulin pens and vials, as well as to include resident identifiers, was found to be inconsistent with this policy. This deficiency had the potential to affect six residents who received insulin on the affected halls.